Study Cohort
Patients (n=63) diagnosed with SARS-CoV-2 infection by Real-Time PCR from respiratory specimens (Altona Diagnostics, Hamburg, Germany) were enrolled into the study at Marburg University Hospital (Germany) between March and November 2020. The baseline characteristics of the study population are shown in Table S1.